PCN6 Matching-Adjusted Indirect Treatment Comparisons (MAIC) of the Effect of Lorlatinib Versus Chemotherapy on Overall Survival (OS) and Progression-Free Survival (PFS) for Patients with Second-LINE or Later Anaplastic Lymphoma Kinase (ALK ...
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.143
https://www.valueinhealthjournal.com/article/S1098-3015(20)32399-8/fulltext
Title :
PCN6 Matching-Adjusted Indirect Treatment Comparisons (MAIC) of the Effect of Lorlatinib Versus Chemotherapy on Overall Survival (OS) and Progression-Free Survival (PFS) for Patients with Second-LINE or Later Anaplastic Lymphoma Kinase (ALK ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32399-8&doi=10.1016/j.jval.2020.08.143
First page :
Section Title :
Open access? :
No
Section Order :
10101